Connecting stakeholders across the healthcare ecosystem.
Public company, workplace, funding, and market signals
Updated Aug 2, 2026
H1 Insights, Inc. (h1.co) is a privately held healthcare-data and software company whose AI-powered platform integrates fragmented healthcare information to identify, understand, and match doctors across clinical research, medical affairs, commercialization, referrals, patient care, and health-plan operations. Its core data model is the continuously learning “Doctor Graph.” H1 says it serves life sciences, payers, providers, and digital-health organizations, with 85% of the top 20 pharmaceutical companies and 9 of the top 10 payers represented among its customers or market penetration claims.
Primary product
An enterprise AI healthcare intelligence platform built around the Doctor Graph, with HCP/Medical, Clinical (including Site Universe and clinical-trial feasibility), Commercial, Patient/Provider, and Health Plans & Digital Health products.
Founded
2017
Headquarters
373 Park Avenue South, 4th Floor, New York, NY 10016, United States
Team size
Approximately 200–300+; third-party estimates range from 286 to 500+, while H1’s About page says it employs over 300. Current public figures conflict.
Work style
Flexible
Industry
Software Development / Healthcare Information Technology
Sub-industry
Healthcare data, analytics, provider intelligence, clinical-trial technology, and health-plan provider-data management
Offices
Business model
Stage
Late-stage private / growth-stage; reported Series C extension and a 2026 strategic investment
Total raised
$345M
Latest round
Strategic investment / Series C extension (reported as Series D-II by some databases) · May 2026
Latest amount
$40M
May 2026 · CVS Health Ventures
Strategic investment / Series C extension
May 2026 · CVS Health Ventures
Dec 2024 · Institutional Venture Partners and Menlo Ventures
Jan 2024
Jun 2022
Jun 2022 · Undisclosed investors
Jun 2022 · Goldman Sachs Asset Management, Menlo Ventures, Transformation Capital, and Novartis Pharma AG
Jun 2022 · Goldman Sachs Asset Management, Menlo Ventures, Transformation Capital, and Novartis dRx Capital
Nov 2021 · Altimeter Capital
Dec 2020 · IVP and Menlo Ventures
Apr 2020 · Menlo Ventures
Shore Group incubation/investment
Oct 2018 · Shore Group
Leadership
Co-Founder & CEO
Co-Founder & President
Vice President of Engineering
Vice President of Product, Health Plans
SVP, People
Karen Walker
Board Member
Steve Hahn
Board Member; former FDA Commissioner
Mike Derezin
Board Member
Greg Yap
Board Member / Menlo Ventures
Somesh Dash
Board Member / IVP
Investors
H1 describes a purpose-driven, fast-moving culture organized around six values: Start with the User, People Matter, Know Why, Beautiful Polished Rocks, Be Quick but Don’t Rush, and One Team. It emphasizes ownership, initiative, feedback, meaningful healthcare impact, and human-led hiring decisions despite using AI tools to analyze applications.
Work style
Flexible
Compensation
Public postings and the careers page signal stock options and retirement benefits, but no reliable company-wide salary bands or verified compensation benchmarks were found.
Benefits
Pricing
Not publicly listed; appears to be quote-based enterprise SaaS/data licensing with demos, APIs, implementation, and custom workflows.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approximately $58M–$148M annually, depending on the third-party estimator and definition used. GetLatka estimated $58.1M ARR for 2025; another company-data profile estimates $148M annual revenue. Neither is audited.
H1 acquired Ribbon Health in a cash-and-stock transaction with undisclosed consideration. The deal broadened H1 into health-plan, provider-system, and digital-health markets; integration and execution remain material business risks.
SourceH1 acquired Veda Data Solutions to add provider-roster automation, data validation, and payer/provider-data management. Financial terms were not disclosed.
SourceH1 acquired Carevoyance to expand into medical-device data and intelligence.
SourceH1 acquired Faculty Opinions Ltd. to broaden its global doctor and scientific-information network.
SourceH1 stated that it was profitable and targeting an “above Rule of 40” profile in 2026. TechCrunch reported that H1 became cash-flow and EBITDA profitable in the prior year; these are company/press claims rather than audited public-company disclosures.
SourceTechCrunch · May 2026
CVS Health Ventures led a $40M investment. H1 said it was profitable and had been valued at $750M in its 2021 financing.
H1 · May 2026
H1 announced the strategic investment and described the collaboration’s provider-directory accuracy and AI implications.
H1 blog · Mar 2026
H1 explained its embedded AI, protocol-aware site recommendations, natural-language search, feasibility workflows, and support for customer data lakes and internal AI/ML.
Fierce Healthcare · Jun 2025
Coverage of H1’s acquisition of Veda and its strategy to build an end-to-end provider-data platform.
H1 · Jun 2025
H1 acquired Veda Data Solutions to strengthen provider data management for health plans and providers.